Journal of Clinical Oncology (JCO) Podcast

View Top 200 Chart

Back to Rankings Page

Health & Fitness
**Journal of Clinical Oncology (JCO) Podcast**

The Journal of Clinical Oncology Podcast presents analyses and discussions centered on the latest findings published in ASCO’s flagship Journal of Clinical Oncology. Host Dr. Davide Soldato facilitates interviews and scholarly discourse on the most impactful published findings. The Journal of Clinical Oncology Podcast is the trusted resource that empowers you to integrate cutting-edge evidence into clinical practice.

The year’s fellows interview authors and summarize the top Journal of Clinical Oncology articles in the series, JCO Article Insights.

Latest Episodes:

Menopausal Hormone Therapy, Mammographic Density and Breast Cancer Jun 23, 2011

Show notes

Estrogen plus progestin and estrogen alone have different effects on mammographic density and breast cancer.

The Growing Value of Risk Calculators for Men Considering Prostate Cancer Screening Jun 20, 2011

Show notes

This is a commentary on a recent study comparing two risk calculators for use in the setting of prostate cancer screening.

Interpretation of the Biomarker Analysis and Final Overall Survival Results from IPASS Jun 13, 2011

Show notes

This podcast describes the analysis of the IPASS study population by EGFR mutation and EGFR FISH biomarker status, and also discusses the results and controversial analysis of overall survival from this trial.

Curing Leukemia with a Single Drug Jun 06, 2011

Show notes

The use of arsenic trioxide as a single agent can produce long lasting remissions and a significant cure rate in patients with acute promyelocytic leukemia.

Vaccination with an Autologous Idiotype Based Vaccine Following a Chemotherapy Induced Remission Holds Promise in the Treatment of Patients with Follicular Lymphoma May 31, 2011

Show notes

In this podcast, results of randomized phase III clinical trial evaluating the effects of a patient specific idiotype tumor vaccine in patients with follicular lymphoma are summarized. The results demonstrate that idiotype vaccination may improve disease free survival in patients with follicular lymphoma who achieve a remission following chemotherapy.

Pathologic Complete Response and Toxicity Results from the STAR-01 Trial Evaluating the Addition of Oxaliplatin to Neodjuvant Chemoradiation for Locally Advanced Rectal Cancer May 23, 2011

Show notes

The addition of oxaliplatin to fluorouracil-based neoadjvuant chemoradiation for locally advanced rectal cancer significantly increases toxicity but does not improve the pathologic complete response rate.

MEK Inhibitors May 16, 2011

Show notes

The term targeted therapy is often used in cancer drug development. This podcast will discuss the study of a mEK inhibitor where the investigators actually looked at the impact on the target as well as whether the drug worked or did not work.

Angiogenic Therapy in Breast Cancer: Axitinib with Chemotherapy Joins the Crowd May 09, 2011

Show notes

Commentary on a new small molecule inhibitor of angiogenesis in combination with chemotherapy for metastatic breast cancer.

Advanced Radiation Therapy Technology Improves Survival in Lung Cancer May 02, 2011

Show notes

This SEER based study demonstrated that the advanced radiation therapy technique of three-dimensional conformal radiation therapy improved survival compared to the previously used method.

The Dark Side of del(5q) MDS Apr 25, 2011

Show notes

This podcast will discuss the basic background of myelodysplastic syndromes and the clinical implications of TP53 mutations predicting outcomes in del(5q) MDS.